Bronchodilator Efficacy of a Single-Dose 12/400-µg Formoterol/Budesonide Combination as a Dry Powder for Inhalation Delivered by Discair
| Autor: | Pinar, Yildiz, Mesut, Bayraktaroglu, Didem, Gorgun, Kivanc, Yuksel |
|---|---|
| Rok vydání: | 2019 |
| Předmět: |
Male
Dry Powder Inhalers Middle Aged Severity of Illness Index Bronchodilator Agents Respiratory Function Tests Pulmonary Disease Chronic Obstructive Drug Delivery Systems Treatment Outcome Forced Expiratory Volume Formoterol Fumarate Administration Inhalation Humans Metered Dose Inhalers Budesonide Aged |
| Zdroj: | Clinical drug investigation. 39(10) |
| ISSN: | 1179-1918 |
| Popis: | A patient-friendly and easy-to-use multi-dose dry powder inhaler, DiscairA total of 33 male patients with moderate-to-severe, chronic obstructive pulmonary disease were included in this single-arm, open-label, phase IV trial. The primary efficacy parameters were the average maximum change in forced expiratory volume in 1 s (FEVThe mean post-bronchodilator FEVOur findings revealed significant changes from baseline in post-bronchodilator peak and average FEVClinicalTrials.gov Identifier NCT03028701. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink